Clinical stage biotechnology company pioneering RNA activation based medicines
MiNA Therapeutics has raised €25M across 1 funding round from 1 investor, most recently a Series A round in Sep 2020. Based in London, UK; founded 2008; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-10 | Series A |
| €25M |
| aMoon Fund |
| View deal → |
